Navigation Links
Endologix Reports 22% Second Quarter 2011 Revenue Growth
Date:7/21/2011

mpared with $12.8 million in the second quarter of 2010, and an 8% increase sequentially from the first quarter of 2011.  International revenue was $2.6 million, an 11% decrease compared with $2.9 million in the second quarter of 2010, and a 19% decrease sequentially from the first quarter of 2011.  The decrease in international revenue was the result of lower sales of Endologix products to the Company's primary distributor in Europe, LeMaitre Vascular.  The Companies announced an early termination agreement for LeMaitre's European distribution rights of Endologix products on July 18, 2011.  The agreement will take effect September 1, 2011.

For the six months ended June 30, 2011, total revenue increased 25% to $37.7 million, compared with $30.1 million for the six months ended June 30, 2010.

Gross profit was $15.0 million in the second quarter of 2011, which represents a gross margin of 78.4%.  This compares with gross profit of $12.0 million and a gross margin of 76.9% in the second quarter of 2010. Gross profit was $29.2 million for the six months ended June 30, 2011, representing a gross margin of 77.4%.  This compares with gross profit of $23.2 million and a gross margin of 76.9% for the six months ended June 30, 2010.  Higher gross margin for the three and six months ended June 30, 2011 was driven by more favorable product mix associated with new products launched in the second half of 2010, and by faster overall revenue growth in the higher margin domestic market.

Total operating expenses were $20.2 million in the second quarter of 2011, a 65% increase compared with $12.2 million in the second quarter of 2010. Of this $8.0 million increase, $3.5 million is related to the Nellix acquisition, including the ongoing technology development work, the establishment of a direct sales organization in Europe, and general integration expenses.

Marketing and sales expenses increased to $10.8 million in the sec
'/>"/>

SOURCE Endologix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Endologix Comments on Alleged Patent Infringement
2. Endologix Responds to Alleged Patent Infringement
3. Endologix to Report Third Quarter 2009 Financial Results on October 27, 2009
4. Endologix Reports 47% Third Quarter 2009 Revenue Growth
5. Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement
6. Endologix Enters Development Agreement and Exclusive License for Balloon Expandable Stent Technology
7. Endologix Receives CE Mark Approval for Expanded Line of Powerlink Products and PowerFit Aortic Extensions
8. Endologix to Report Third Quarter 2010 Financial Results on October 27, 2010
9. Endologix Announces Publication of Clinical Trial Results Supporting Anatomical Fixation with a Suprarenal Aortic Extension
10. Endologix to Present at Oppenheimer 21st Annual Healthcare Conference
11. Endologix Reports 30% Third Quarter 2010 Revenue Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... DUBLIN , Sep. 04, 2015 ... ) has announced the addition of the ... - December 7-8, 2015)" conference to their ... take participants through all of the constituent parts ... veterinary medicinal product for which a marketing authorisation ...
(Date:9/4/2015)... , September 4, 2015 ... today announces that Hutchison MediPharma Limited ("HMP"), its ... in the second proof-of-concept ("POC") trial of fruquintinib ... cancer ("NSCLC") in China . ... succeeded in meeting the primary efficacy endpoint of ...
(Date:9/3/2015)... -- With a population of more than 1 billion, ... its single largest potential market for goods and services. ... major world economies in the average rate of growth ... expenditures. As an in vitro diagnostics (IVD) market, China ... States, western European countries, and Japan. China represents one ...
Breaking Medicine Technology:Veterinary Pharmaceutical Submissions in the EU: Two day Course - London, UK - December 7-8, 2015 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 3IVD in China 2IVD in China 3IVD in China 4IVD in China 5IVD in China 6IVD in China 7IVD in China 8IVD in China 9IVD in China 10IVD in China 11IVD in China 12IVD in China 13
... Elanco, the animal health division of Eli Lilly and ... Lilly has signed an agreement to acquire ChemGen Corp., ... and commercialization of innovative feed enzyme products that improve ... enzymes are naturally occurring digestive enhancers that can help ...
... Jan. 24, 2012 Thomson CompuMark , the ... and part of Thomson Reuters, today announced the launch ... providing targeted, global trademark intelligence in a single online ... which can sometimes lead to prescription errors, is a ...
Cached Medicine Technology:Elanco Animal Health Announces Lilly's Agreement to Acquire ChemGen Corp. 2Elanco Animal Health Announces Lilly's Agreement to Acquire ChemGen Corp. 3Elanco Animal Health Announces Lilly's Agreement to Acquire ChemGen Corp. 4Thomson CompuMark Reduces Drug Approval Delays by Identifying Conflicting Trademarks in International Markets 2Thomson CompuMark Reduces Drug Approval Delays by Identifying Conflicting Trademarks in International Markets 3
(Date:9/4/2015)... ... September 04, 2015 , ... Mile High Connects today releases “First and ... of funding for sidewalks, bike paths, and other vital supports severely limit access to ... spends billions of dollars to expand public transit, there’s very little support for safe ...
(Date:9/4/2015)... Marietta, GA (PRWEB) , ... September 04, 2015 , ... ... team is in desperate need of new apparel. In an effort to assist the ... around Marietta, has launched a charity drive to raise funds for the new uniforms. ...
(Date:9/4/2015)... ... September 04, 2015 , ... San Francisco ... at CitiDent. CEREC is a newer method for creating restorations through innovative imaging ... by eliminating the need for multiple appointments, CEREC produces restorations with total precision ...
(Date:9/4/2015)... ... 2015 , ... The USC Eye Institute is proud to announce that the ... Faculty, residents and staff are honored to have contributed to the success of our ... residency program. Our faculty places a high priority on our educational programs in training ...
(Date:9/4/2015)... ... September 04, 2015 , ... ... in South Glastonbury, Connecticut, has been selected for the Residential Award of Merit ... efficiency and resiliency measures. Chosen from a highly competitive field of submissions, the ...
Breaking Medicine News(10 mins):Health News:Missed Connections in Metro Denver Transit 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 3Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 3Health News:South Glastonbury Home Selected for Award by Connecticut Green Building Council 2
... May 9 VNUS(R) Medical,Technologies, Inc. today announced that ... a second continuation patent application related to,the patents in ... products. This comes on the heels of the Patent ... application, also filed,as a continuation of one of the ...
... of compound in fried foods, snacks, coffee upped chances ... Consuming large amounts of acrylamide, a chemical commonly ... appears to raise the risk of kidney cancer, especially ... first report of a positive association between dietary acrylamide ...
... remains stable; net loss per ... share improves - ... noted), BELLEVILLE, ON, May 9 /PRNewswire-FirstCall/ - Bioniche Life Sciences,Inc. (TSX: ... third,quarter of its 2008 fiscal year, ending March 31, 2008., "One ...
... MedCath Corporation,(Nasdaq: MDTH ) announced that its senior ... Securities 2008 Health Care Conference,held May 13 - 15 ... MedCath,s senior management will give its presentation on Tuesday, ... be web cast live over,the Internet via MedCath,s website ...
... BMR, TORONTO, May 9 /PRNewswire-FirstCall/ - ... in the development and,commercialization of cancer therapies, ... financial results., Operational Highlights, During ... the Company achieved the,following steps in preparation ...
... Two Operations Leads to Indictment of 11,Defendants in ... people have been,indicted in the second phase of ... and health care companies that,fraudulently bill the Medicare ... S. Fisher and U.S. Attorney for the Central,District ...
Cached Medicine News:Health News:U.S. Patent Office Allows Another Significant VNUS Patent 2Health News:U.S. Patent Office Allows Another Significant VNUS Patent 3Health News:Acrylamide Raises Kidney Cancer Risk 2Health News:Acrylamide Raises Kidney Cancer Risk 3Health News:Bioniche Reports Fiscal 2008 Third Quarter 2Health News:Bioniche Reports Fiscal 2008 Third Quarter 3Health News:Bioniche Reports Fiscal 2008 Third Quarter 4Health News:Bioniche Reports Fiscal 2008 Third Quarter 5Health News:Bioniche Reports Fiscal 2008 Third Quarter 6Health News:Bioniche Reports Fiscal 2008 Third Quarter 7Health News:Bioniche Reports Fiscal 2008 Third Quarter 8Health News:Bioniche Reports Fiscal 2008 Third Quarter 9Health News:Bioniche Reports Fiscal 2008 Third Quarter 10Health News:Bioniche Reports Fiscal 2008 Third Quarter 11Health News:Bioniche Reports Fiscal 2008 Third Quarter 12Health News:Bioniche Reports Fiscal 2008 Third Quarter 13Health News:Bioniche Reports Fiscal 2008 Third Quarter 14Health News:Bioniche Reports Fiscal 2008 Third Quarter 15Health News:Bradmer announces 2008 first quarter operational and financial results 2Health News:Bradmer announces 2008 first quarter operational and financial results 3Health News:Bradmer announces 2008 first quarter operational and financial results 4Health News:Bradmer announces 2008 first quarter operational and financial results 5Health News:Bradmer announces 2008 first quarter operational and financial results 6Health News:Bradmer announces 2008 first quarter operational and financial results 7Health News:Bradmer announces 2008 first quarter operational and financial results 8Health News:Strike Force Targets Medicare Fraud By Los Angeles Area Health Care Companies 2Health News:Strike Force Targets Medicare Fraud By Los Angeles Area Health Care Companies 3Health News:Strike Force Targets Medicare Fraud By Los Angeles Area Health Care Companies 4Health News:Strike Force Targets Medicare Fraud By Los Angeles Area Health Care Companies 5
... mapping software system enhances clinical evaluations with ... corneal maps. The system offers an enlarged ... refractive and keratometric data, and peripheral keratometric ... subclinical keratoconus as well as pre and ...
... SS-3 Screenoscope provides fast, accurate, and reliable tests ... optical system duplicates conditions for viewing far point ... conditions for near point test charts at 30cm ... operate, incorporates test charts that can be interchanged ...
... OM-4 Ophthalmometer (Sutcliff Type) ... and easy to use ... objective measurements of the ... plus accurate measurements of ...
... the latest digital chip technology, the new ... Topcon features 3,072 x 2,048 pixels resolution ... color channel! The system provides exceptionally sharp ... image acquisition, which facilitates instant diagnosis by ...
Medicine Products: